What is Bayer Aktiengesellschaft (BAYN.DE)?

Bayer Aktiengesellschaft (BAYN.DE) is a stock in the Healthcare sector, Drug Manufacturers - General industry. View full analysis on Stocks360.

Bayer Aktiengesellschaft (BAYN.DE)

Stock analysis · XETRA · Healthcare · Drug Manufacturers - General

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.84

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Bayer Aktiengesellschaft (BAYN.DE) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Aug 4, 2026

EPS $0.94 vs est. $0.76

Beat by $0.18

Proprietary Signals

Signal snapshot temporarily unavailable.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmac…